Arkivum provides pioneering e-archive to Idorsia Pharmaceuticals delivering GxP compliant long-term access to valuable product and clinical trial data
Idorsia Pharmaceuticals, headquartered near Basel, Switzerland; has selected Arkivum to safeguard and digitally preserve their valuable research and clinical trial data. A relatively new company born out of a de-merger of Actelion (who were bought by Johnson and Johnson); Idorsia has been created as a completely new company and required an e-archive solution to not only store a large amount of its data but also to provide secure access for future use.
The data includes previous Actelion data, data relating to inherited products returning from CROs and service providers, as well as data being generated by Idorsia itself.
Testimonial
We were looking for the confidence that in 20/30/50 years’ time we can provide evidence if an auditor comes in and asks to see all documentation relating to a specific product or clinical trial; proving the integrity, chain of custody and the audit trail of our data
Ready to find out more?
Submit your details below for a personalised demo showing how your organisation could be benefitting from long-term data management today. Fields marked with an * are required. Need more information? See our blog or contact us.
Suggested reading
02 Sep, 2019
Arkivum provides pioneering e-archive to Idorsia Pharmaceuticals delivering GxP compliant long-term access to valuable product and clinical trial data
20 May, 2019
Oncologica, a leading pharmaceutical CRO, selects Arkivum to provide integrated long-term data management of their next-generation sequencing data
16 Jul, 2019
